May 21
In recent years, emerging markets have been touted as an affordable and attractive labor pool for the outsourcing of pharmaceutical and biotechnology projects.
|
May 21
Type 1 ultrapure water is by far the purest substance used in a laboratory. This article discusses the high level of purity of type I ultrapure water, the importance of such purity and how to maintain this standard during normal laboratory use
|
May 16
When selecting a regulator, you are not just looking for the right size. You’re looking for a set of capabilities, which is a function of the regulator’s design. A flow curve illustrates the regulator’s range of capabilities at one glance. Once you understand a flow curve – and we’ll explain how – it is easy and very quick to read.
|
May 16
Over the past few years, there has been a growing awareness of the unique benefits of delivering vaccines intradermally. Potential benefits include improved vaccine safety, increased vaccine effectiveness, and enhanced immunogenicity in hard to vaccinate populations such as the elderly.
|
May 15
New technology developments such as industrial wireless are having a profound effect on plant operating strategies. By enabling greater workforce mobility and connectivity, wireless allows manufacturers to diversify production, and change from a single-chain product to producing multi-chain products, in an efficient and flexible way to help meet the needs of patients.
|
May 15
A product recall is problematic for any manufacturer. In the last year alone, recalls of pharmaceutical and health-related products have included baby lotions, parenteral nutrition products, nasal decongestant sprays and alcohol swabs used in preparation for patient injections—all resulting from microbial contamination.
|
May 7
Line Performance OptimizationSM (LPO) integrates best practices in asset management, lean and change management to solve chronic and persistent reliability issues with a specific manufacturing line.
|
Apr 27
Very simply, the aim of pharmaceutical development is to design a quality product and manufacturing process to consistently deliver the intended performance of a final therapeutic product.
|
Apr 26
How to evaluate opportunities for continuous powder blending.
|
Apr 26
How both are impacting biopharmaceutical manufacturing and CMOs.
|